Successful treatment of multidrug-resistant Pseudomonas aeruginosa breakthrough bacteremia with ceftolozane/tazobactam

被引：0
|
作者：
Alberto Hernández-Tejedor
Carmen Débora Merino-Vega
Alfredo Martín-Vivas
Rafael Ruiz de Luna-González
Alberto Delgado-Iribarren
Ángeles Gabán-Díez
Ignacio Temprano-Gómez
Natalia de la Calle-Pedrosa
Ana Isabel González-Jiménez
Alejandro Algora-Weber
机构：
[1] Hospital Universitario Fundación Alcorcón,Unidad de Cuidados Críticos
[2] Hospital Universitario Fundación Alcorcón,Unidad de Microbiología
来源：
Infection | 2017年 / 45卷
关键词：
Ceftolozane/tazobactam; Multidrug-resistant ; Bacteremia;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：115 / 117
页数：2
相关论文
共 50 条
  • [31] Continuous infusion of ceftolozane-tazobactam resulted in high cerebrospinal fluid concentrations of ceftolozane in a patient with multidrug-resistant Pseudomonas aeruginosa meningitis
    S. Alexander Winans
    Richelle L. Guerrero-Wooley
    Susie H. Park
    Garret Hino
    Steven C. Forland
    Infection, 2021, 49 : 355 - 359
  • [32] Ceftolozane/Tazobactam Dosing Requirements Against Pseudomonas aeruginosa Bacteremia
    Ruiz, Jesus
    Ferrada, Alejandra
    Salavert, Miguel
    Gordon, Monica
    Villarreal, Esther
    Castellanos-Ortega, Alvaro
    Ramirez, Paula
    DOSE-RESPONSE, 2020, 18 (01):
  • [33] Ceftolozane-Tazobactam Versus Ceftazidime-Avibactam for the Treatment of Infections Caused by Multidrug-Resistant Pseudomonas aeruginosa: a Multicenter Cohort Study
    Almangour, Thamer A.
    Ghonem, Leen
    Alassiri, Dareen
    Aljurbua, Alanoud
    Al Musawa, Mohammed
    Alharbi, Aminah
    Almohaizeie, Abdullah
    Almuhisen, Sara
    Alghaith, Jeelan
    Damfu, Nader
    Aljefri, Doaa
    Alfahad, Wafa
    Khormi, Yaqoub
    Alanazi, Menyfah Q.
    Alsowaida, Yazed Saleh
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2023, 67 (08)
  • [34] A Review of Ceftolozane/Tazobactam for the Treatment of Infections Caused by Multidrug-Resistant Pathogens
    Sebaaly, Jamielynn
    Woods, Joseph Andrew
    Wargo, Kurt A.
    INFECTIOUS DISEASES IN CLINICAL PRACTICE, 2018, 26 (04) : 198 - 203
  • [35] Impact of Multidrug-Resistant Pseudomonas aeruginosa Bacteremia on Patient Outcomes
    Tam, Vincent H.
    Rogers, Cary A.
    Chang, Kai-Tai
    Weston, Jaye S.
    Caeiro, Juan-Pablo
    Garey, Kevin W.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2010, 54 (09) : 3717 - 3722
  • [36] Use of Continuous-Infusion Ceftolozane/Tazobactam in a Multidrug-Resistant Pseudomonas aeruginosa Urinary Tract Infection in the Outpatient Setting
    Jones, Bruce M.
    Smith, Bradley
    Bland, Christopher M.
    ANNALS OF PHARMACOTHERAPY, 2017, 51 (08) : 715 - 716
  • [37] In Vitro Hollow-Fiber Studies Assessing Antibacterial Activity of Ceftolozane/Tazobactam Against Multidrug-Resistant Pseudomonas Aeruginosa
    Carr, Donna
    Zhang, Zufei
    Si, Qian
    Racine, Fred
    Xiao, Jing Chen
    Katwaru, Ravi
    Wismer, Michael K.
    Johnson, Matthew G.
    Feng, Hwa-Ping
    Young, Katherine
    Rizk, Matthew L.
    Motyl, Mary
    OPEN FORUM INFECTIOUS DISEASES, 2020, 7 (11):
  • [38] Efficacy of ceftolozane/tazobactam, alone and in combination with colistin, against multidrug-resistant Pseudomonas aeruginosa in an in vitro biofilm pharmacodynamic model
    Gomez-Junyent, Joan
    Benavent, Eva
    Sierra, Yanik
    El Haj, Cristina
    Soldevila, Laura
    Torrejon, Benjamin
    Rigo-Bonnin, Raul
    Tubau, Fe
    Ariza, Javier
    Murillo, Oscar
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2019, 53 (05) : 612 - 619
  • [39] Intravitreal piperacillin/tazobactam in the management of multidrug-resistant Pseudomonas aeruginosa endophthalmitis
    Pathengay, Avinash
    Mathai, Annie
    Shah, Gaurav Y.
    Ambatipudi, Srinivas
    JOURNAL OF CATARACT AND REFRACTIVE SURGERY, 2010, 36 (12): : 2210 - 2211
  • [40] Real life experience with ceftolozane/tazobactam therapy for Pseudomonas aeruginosa bacteremia
    Khan, Sumaira
    Phe, Kady
    Tam, Vincent H.
    JOURNAL OF CHEMOTHERAPY, 2021, 33 (08) : 595 - 597
12345